Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Roche to launch new MS collaboration

June 23, 2014 Research and Development, Sales and Marketing MS, Roche, inception sciences, multiple sclerosis, versant ventures

Roche has launched a new research collaboration to investigate ways of reversing the debilitating nerve damage caused by multiple sclerosis …
News

Novartis back under microscope

June 23, 2014 Medical Communications, Sales and Marketing Italy, Novartis, avastin, fraud, influenza, vaccines

Novartis is under the microscope yet again in Italy, with police visiting the company’s sites at Siena and Origgio in …
News

Life Sciences Hub Wales – new COO and
 board



June 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Hub Wales, Wales, ian barwick

Dr Ian Barwick has been appointed chief operating officer for Life Sciences Hub Wales along with several new board members.
  …
Appointment

£100 million funding stream aids UK biotech

June 23, 2014 Research and Development, Sales and Marketing BIA, Steve Bates, biomedical catalyst, funding

UK biotech companies are developing new therapies for cancer, Parkinson’s, diabetes and tinnitus as a direct result of the £100 …
News

Drug prices defy gravity – until patent expiry

June 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina, LaMattina, Pfizer, drug, pharma, pricing, research

How drugs are priced is a hot topic these days, and a new Bloomberg article will cause it to heat-up …
Feature

Conversis Medical hires global director

June 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing conversis, hooper, medical

Medical translation agency Conversis Medical has appointed Dr Mark Hooper as its global director. Hooper has worked in the pharma …
Appointment

Boehringer abandons hep C

June 23, 2014 Research and Development, Sales and Marketing AbbVie, Boehringer, HCV, faldaprevir, german, hep C

Boehringer Ingelheim has abandoned its hepatitis C (HCV) drug development programme as a dead loss after ‘re-evaluating’ its strategy. The …
News

Lilly’s Efient tipped for expanded NICE approval

June 20, 2014 Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner

 Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …
News

PAN expands creative team with two hires

June 20, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ogilvy, Pan

Creative agency PAN has increased its team by hiring two new people in Minas Maroudas (pictured) who joins as senior …
Appointment

Dementia research ‘achingly slow’

June 20, 2014 Research and Development, Sales and Marketing Alzheimer's, Cameron, Parkinson's, Parkinsons, UK, billings, dementia, research

The UK prime minister’s envoy on dementia has described progress on research into the neurodegenerative condition as ‘achingly slow’. Global …
News

AbbVie moves in on Shire with $46 billion bid

June 20, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger

AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …
News

Novartis emphasises pharma growth

June 19, 2014 Sales and Marketing Novartis, breezhaler, dermatology, heart failure, oncology, respiratory

Novartis is to grow its pharma business by focussing on five key areas and predicts that it will have 14 …
News

Teva chairman stepping down amid revamp

June 19, 2014 Manufacturing and Production, Medical Communications, Sales and Marketing Frost, Levin, Teva, chief, generics, israel, pharma

Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …
News

Valeant goes hostile over Allergan hunt

June 19, 2014 Sales and Marketing Allergan, Botox, Valeant, hostile, takeover

Valeant Pharmaceuticals has turned hostile in its bid to acquire Botox maker Allergan by employing strong-arm tactics in an attempt …
News

£16m dementia research platform launched

June 19, 2014 Research and Development, Sales and Marketing Alzheimer's, MRC, Parkinson's, brain, dementia, ukdp

The Medical Research Council (MRC) has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026